An editorial perspective on the infamous COVID-19 studies retracted by Lancet and NEJM.
作者信息
Sengupta Sabyasachi
机构信息
Associate Editor, Indian Journal of Ophthalmology, Future Vision Eye Care and Research Centre, Mumbai, Maharashtra, India.
出版信息
Indian J Ophthalmol. 2020 Jul;68(7):1247-1248. doi: 10.4103/ijo.IJO_1853_20.
Abstract
摘要
相似文献
1
An editorial perspective on the infamous COVID-19 studies retracted by Lancet and NEJM.《柳叶刀》和《新英格兰医学杂志》撤回的臭名昭著的新冠病毒研究的编辑观点。
Indian J Ophthalmol. 2020 Jul;68(7):1247-1248. doi: 10.4103/ijo.IJO_1853_20.
2
The importance of robust research methodology in the era of COVID-19 and beyond.强大的研究方法在新冠疫情时代及以后的重要性。
Can J Ophthalmol. 2020 Oct;55(5):347-348. doi: 10.1016/j.jcjo.2020.09.002.
3
Retraction of Studies on Potential Drug Therapies for COVID-19: A Call for Reliability and Scientific Integrity.撤回关于COVID-19潜在药物疗法的研究：呼吁可靠性和科学诚信。
Am J Cardiol. 2020 Oct 1;132:173. doi: 10.1016/j.amjcard.2020.06.061. Epub 2020 Jun 30.
4
An expression of concern on research during the Covid-19 pandemic.关于新冠疫情期间研究的关注声明。
J Cardiovasc Med (Hagerstown). 2020 Oct;21(10):838-839. doi: 10.2459/JCM.0000000000001074.
5
COVID-19 and Biomedical Publishing: Challenges and Prospects.新冠疫情与生物医学出版：挑战与前景
J Coll Physicians Surg Pak. 2020 Oct;30(10):92-93. doi: 10.29271/jcpsp.2020.supp2.92.
6
Human biology is a matter of life or death: Effective science communication for COVID-19 research.人类生物学关乎生死：新冠病毒研究的有效科学传播
Am J Hum Biol. 2020 Sep;32(5):e23472. doi: 10.1002/ajhb.23472. Epub 2020 Jul 31.
7
Editorial note about SARS-CoV-2 in the pandemic era.关于大流行时代严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的编者按。
Biomedica. 2020 Oct 30;40(Supl. 2):14-15.
8
Critical care journals during the COVID-19 pandemic: challenges and responsibilities.新冠疫情期间的重症监护期刊：挑战与责任
Intensive Care Med. 2020 Aug;46(8):1521-1523. doi: 10.1007/s00134-020-06155-7. Epub 2020 Jul 6.
9
Publishing in the time of pandemic: Editorial policy of a dermatology journal during COVID-19.疫情期间的出版：COVID-19 期间一本皮肤科杂志的编辑政策
Indian J Dermatol Venereol Leprol. 2020 Jul-Aug;86(4):337-340. doi: 10.4103/ijdvl.IJDVL_704_20.
10
The Landscape of Medical Literature in the Era of COVID-19: Original Research Versus Opinion Pieces.新冠疫情时代的医学文献格局：原创研究与观点文章
J Gen Intern Med. 2020 Sep;35(9):2813-2815. doi: 10.1007/s11606-020-06021-8. Epub 2020 Jul 8.
引用本文的文献
1
Lessons learnt from the International Peer Review Week 2022 with the theme - "Research Integrity: Creating and supporting trust in research".从2022年国际同行评审周汲取的经验教训，主题为——“研究诚信：建立并支持对研究的信任”。
Indian J Ophthalmol. 2022 Dec;70(12):4099-4100. doi: 10.4103/IJO.IJO_2920_22.
2
The extent of scam in the scientific world - How intellectual can the scam appear?科学界欺诈行为的程度——欺诈行为能显得多具学术性？
J Optom. 2021 Jul-Sep;14(3):295-296. doi: 10.1016/j.optom.2020.09.001. Epub 2021 Jan 5.
3
Changes in the Scientific Information Environment During the COVID-19 Pandemic: The Importance of Scientific Situational Awareness in Responding to the Infodemic.新冠疫情期间科学信息环境的变化：科学态势感知在应对信息疫情中的重要性。
Health Secur. 2021 Jan-Feb;19(1):82-87. doi: 10.1089/hs.2020.0194. Epub 2020 Dec 17.
4
Comments on: An editorial perspective on the infamous COVID-19 studies retracted by Lancet and NEJM.关于《柳叶刀》和《新英格兰医学杂志》撤回的臭名昭著的新冠病毒研究的社论观点评论。
Indian J Ophthalmol. 2021 Jan;69(1):157. doi: 10.4103/ijo.IJO_3029_20.
5
World Lung Day 2020 at the and the .2020年世界肺部日在……和……举行。 （你提供的原文不完整，这里只是按要求翻译现有内容）
Am J Physiol Lung Cell Mol Physiol. 2020 Sep 1;319(3):L534-L537. doi: 10.1152/ajplung.00371.2020. Epub 2020 Aug 5.
本文引用的文献
1
Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.撤稿——羟氯喹或氯喹联合或不联合大环内酯类药物治疗新型冠状病毒肺炎：一项多国注册研究分析
Lancet. 2020 Jun 13;395(10240):1820. doi: 10.1016/S0140-6736(20)31324-6. Epub 2020 Jun 5.
2
Expression of Concern: Mehra MR et al. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.关注声明：梅赫拉·M·R等人。新冠病毒病中的心血管疾病、药物治疗与死亡率。《新英格兰医学杂志》。DOI: 10.1056/NEJMoa2007621
N Engl J Med. 2020 Jun 18;382(25):2464. doi: 10.1056/NEJMe2020822. Epub 2020 Jun 2.
3
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.撤回：羟氯喹或氯喹联合或不联合大环内酯类药物治疗新型冠状病毒肺炎：一项多国注册分析
Lancet. 2020 May 22. doi: 10.1016/S0140-6736(20)31180-6.
4
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.心血管疾病、药物治疗与新冠病毒感染相关死亡率
N Engl J Med. 2020 Jun 18;382(25):e102. doi: 10.1056/NEJMoa2007621. Epub 2020 May 1.
5
Publication ethics.出版伦理
Indian J Ophthalmol. 2017 Jun;65(6):429-432. doi: 10.4103/ijo.IJO_483_17.
Zotero 插件